IDEXX Laboratories, Inc. (IDXX) Financials

IDXX Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 3.4 billion 1.8 billion
2023-12-31 3.3 billion 1.8 billion
2023-09-30 3.1 billion 1.8 billion
2023-06-30 2.9 billion 1.8 billion

IDXX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 168.3 million 14.4 million
2023-12-31 217.3 million 15.2 million
2023-09-30 238.3 million 15.2 million
2023-06-30 172.8 million 15.4 million

IDXX Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 235.6 million
2023-12-31 194.5 million
2023-09-30 212.2 million
2023-06-30 224.2 million

IDXX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 397.4 million - 123.2 million
2023-12-31 453.9 million - 119.5 million
2023-09-30 331.7 million - 121.4 million
2023-06-30 132.8 million 696.8 million 117.0 million

IDXX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 84.0 million
2023-12-31 83.9 million
2023-09-30 84.0 million
2023-06-30 84.0 million

IDXX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 30.3 million 52.6 million 92.0 million 149.5 million
2023-12-31 32.6 million 51.8 million 87.0 million 142.0 million
2023-09-30 34.1 million 48.0 million 89.0 million 135.7 million
2023-06-30 27.5 million 46.5 million 89.7 million 140.5 million

IDXX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 964.1 million 371.0 million
2023-12-31 901.6 million 375.4 million
2023-09-30 915.5 million 367.5 million
2023-06-30 943.6 million 370.8 million

IDXX

Price: $480.60

52 week price:
372.50
583.39

Payout Ratio Range:
1.72%
3.40%

Earnings Per Share: 10.04 USD

P/E Ratio: 57.86

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 353885

Ebitda: 120.9 million

Market Capitalization: 39.3 billion

Links: